: Cardiotoxicity

of 5-fluorouracil in 1350

: Cardiotoxicity

of 5-fluorouracil in 1350 JSH-23 price patients with no prior history of heart disease. Bull Cancer 2006, 93:E27-E30.PubMed 30. Lieutaud T, Brain E, Golgran-Toledano D, et al.: 5-Fluorouracil cardiotoxicity: a unique mechanism for ischaemic cardiopathy and cardiac failure? Eur J Canc 1996, 32a:368–369.CrossRef 31. Çalık AN, Çeliker E, Velibey Y, et al.: Initial dose effect of 5-fluorouracil: rapidly improving severe, acute toxic myopericarditis. Am J Emerg Med 2012,30(1):257.e1-e3.CrossRef 32. Dechant C, Baur M, Böck R, et al.: Acute Reversible Heart Failure Caused by Coronary Vasoconstriction due to Continuous 5-Fluorouracil Combination Chemotherapy. Case Rep Oncol 2012,5(2):296–301.click here PubMedCrossRef 33. Castiglia L, Miraglia N, Pieri M, et al.: Evaluation of occupational

exposure to antiblastic drugs in an Italian hospital oncological department. J Occup Health 2008,50(1):48–56.PubMedCrossRef 34. Büchel B, Rhyn P, Schürch S, et al.: LC-MS/MS method for simultaneous analysis of uracil, 5,6-dihydrouracil, 5-fluorouracil and 5-fluoro-5,6-dihydrouracil in human plasma for therapeutic drug monitoring and toxicity prediction in cancer patients. Biomed Chromatogr 2012,:. 35. Caraglia M, Marra M, Budillon A, et al.: Chemotherapy find more regimen GOLF induces apoptosis in colon cancer cells through multi-chaperone complex inactivation and increased Raf-1 ubiquitin-dependent degradation. Cancer Biol Ther 2005,4(10):1159–1167.PubMedCrossRef 36. Correale P, Marra M, Remondo C, et al.: Cytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity (ADCC). Eur J Cancer

2010,46(9):1703–1711.PubMedCrossRef 37. eltoprazine Alter P, Herzum M, Soufi M, et al.: Cardiotoxicity of 5-fluorouracil. Cardiovasc Hematol Agents Med Chem 2006,4(1):1–5.PubMedCrossRef 38. Oztop I, Gencer M, Okan T, et al.: Evaluation of cardiotoxicity of a combined bolus plus infusional 5-fluorouracil/folinic acid treatment by echocardiography, plasma troponin I level, QT interval and dispersion in patients with gastrointestinal system cancers. Jpn J Clin Oncol 2004,34(5):262–268.PubMedCrossRef 39. Canale ML, Camerini A, Stroppa S, et al.: A case of acute myocardial infarction during 5-fluorouracil infusion. J Cardiovasc Med 2006,7(11):835–837.CrossRef 40. Asensio-López MC, Lax A, Pascual-Figal DA, et al.: Metformin protects against doxorubicin-induced cardiotoxicity: involvement of the adiponectin cardiac system. Free Radic Biol Med 2011,51(10):1861–1871.PubMedCrossRef 41. Lang F, Perrotti N, Stournaras C: Colorectal carcinoma cells–regulation of survival and growth by SGK1. Int J Biochem Cell Biol 2010,42(10):1571–1575.PubMedCrossRef 42. Wong RSY: Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res 2011, 30:87.PubMedCrossRef Competing interests The authors declare that they have no competing interests.

Comments are closed.